Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cytarabine CD4+/CD56+ Hematodermic Neoplasm	Therapeutic Advances in Childhood Leukemia Consortium	P2	B (60)
Cytarabine Hematopoietic And Lymphoid Cell Neoplasm	Senti Biosciences	P2	B (60)
Cytarabine Juvenile Myelomonocytic Leukemia	Children's Oncology Group	P2	B (60)
Cytarabine B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like	City of Hope Medical Center	P2	B (60)
Dabrafenib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	B (60)
Daoib Cognitive Disorder	Chang Gung Memorial Hospital	P2	B (60)
Daratumumab Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (60)
Daratumumab Monoclonal Gammopathy	Hellenic Society of Hematology	P2	B (60)
Daratumumab AA Amyloidosis	City of Hope Medical Center	P2	B (60)
Dasatinib Lymphoma	National Cancer Institute (NCI)	P2	B (60)
Dasatinib Adult Acute Lymphoblastic Leukemia	First Affiliated Hospital Xi'an Jiaotong University	P2	B (60)
Dasatinib Non-Hodgkin Lymphoma	Zhejiang University	P2	B (60)
Datopotamab Deruxtecan Biliary Tract Cancer	AstraZeneca	P2	B (60)
Daunomycin Acute Myeloid Leukemia With Multilineage Dysplasia	National Cancer Institute (NCI)	P2	B (60)
Decitabine Chronic Myeloid Leukemia	M.D. Anderson Cancer Center	P2	B (60)
Decitabine Acute Myeloid Leukemia And Myelodysplastic Syndromes Related To Alkylating Agent	Roswell Park Cancer Institute	P2	B (60)
Decitabine Essential Thrombocythemia	University of Washington	P2	B (60)
Decitabine Acquired Polycythemia Vera	University of Washington	P2	B (60)
Decitabine Primary Myelofibrosis	University of Washington	P2	B (60)
Decitabine Breast Carcinoma	Virginia Commonwealth University	P2	B (60)
Defactinib Endometrioid Adenocarcinoma	University of Oklahoma	P2	B (60)
Dexasone CD4+/CD56+ Hematodermic Neoplasm	Therapeutic Advances in Childhood Leukemia Consortium	P2	B (60)
Dexasone Neutropenia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	B (60)
Dexasone Monoclonal Paraproteinemia Disease	Hellenic Society of Hematology	P2	B (60)
Dinaciclib Melanoma	National Cancer Institute (NCI)	P2	B (60)

Showing 1726 to 1750 of 13,155 assets

PreviousPage 70 of 527Next